Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

NCT00224315 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia, Schizoaffective Disorder

Interventions

DRUG: ziprasidone
DRUG: risperidone

Sponsor

Central Institute of Mental Health, Mannheim